TY - GEN
T1 - Ca2+ Channel Currents in Type I Carotid Body Cells from Normoxic and Chronically Hypoxic Rats
AU - Carpenter, E.
AU - Wyatt, C. N.
AU - Hatton, C. J.
AU - Bee, D.
AU - Peers, C.
PY - 1996
Y1 - 1996
N2 - Rats born and reared under chronically hypoxic (10% O2) conditions do not respond to acute hypoxia with an increased ventilation. Their carotid bodies undergo hyperplasia and hypertrophy and we have recently shown that K+ channels recorded in type I carotid body cells isolated from normal and chronically hypoxic (CH) rats show marked differences (Wyatt et al, 1995): normoxic type I cells express Ca2+-activated K+ (KCa) channels which are inhibited by acute hypoxia, leading to cell depolarization, opening of voltagegated Ca2+ channels (VGCCs) and the consequent influx of Ca2+ to trigger neurotransmitter release (Peers & Buckler, 1995). In type I cells from CH rats, there is far less expression of KCa channels, and, whilst the remaining K+ channels are inhibited by hypoxia, this does not lead to cell depolarization, which may explain the lack of ventilatory response to acutely inspired hypoxia in intact CH rats (Wyatt et al, 1995). An important factor in the response of normal type I cells to hypoxia is the activation of VGCCs, of which numerous sub-types exist in various tissues. It is known that L-type VGCCs are involved in hypoxic chemotransduction (Buckler & Vaughan-Jones, 1994), but very little is known about the possible presence of other VGCCs, whether they may be involved in chemotransduction, and whether they are affected by chronic hypoxia. We have therefore compared the properties of VGCCs in type I carotid body cells isolated from normoxically-reared and CH rats.
AB - Rats born and reared under chronically hypoxic (10% O2) conditions do not respond to acute hypoxia with an increased ventilation. Their carotid bodies undergo hyperplasia and hypertrophy and we have recently shown that K+ channels recorded in type I carotid body cells isolated from normal and chronically hypoxic (CH) rats show marked differences (Wyatt et al, 1995): normoxic type I cells express Ca2+-activated K+ (KCa) channels which are inhibited by acute hypoxia, leading to cell depolarization, opening of voltagegated Ca2+ channels (VGCCs) and the consequent influx of Ca2+ to trigger neurotransmitter release (Peers & Buckler, 1995). In type I cells from CH rats, there is far less expression of KCa channels, and, whilst the remaining K+ channels are inhibited by hypoxia, this does not lead to cell depolarization, which may explain the lack of ventilatory response to acutely inspired hypoxia in intact CH rats (Wyatt et al, 1995). An important factor in the response of normal type I cells to hypoxia is the activation of VGCCs, of which numerous sub-types exist in various tissues. It is known that L-type VGCCs are involved in hypoxic chemotransduction (Buckler & Vaughan-Jones, 1994), but very little is known about the possible presence of other VGCCs, whether they may be involved in chemotransduction, and whether they are affected by chronic hypoxia. We have therefore compared the properties of VGCCs in type I carotid body cells isolated from normoxically-reared and CH rats.
KW - Calcium/metabolism
KW - Calcium Channels/metabolism
KW - Carotid Body/metabolism
KW - Hypoxia/metabolism
KW - Nerve Tissue Proteins/metabolism
KW - 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/pharmacology
KW - ; Action Potentials/drug effects
KW - Animals
KW - Calcium Channel Blockers/pharmacology
KW - Calcium Channels/classification
KW - Calcium Channels/drug effects
KW - Calcium Channels, L-Type
KW - Carotid Body/drug effects
KW - Carotid Body/pathology
KW - Cell Hypoxia
KW - Cells, Cultured
KW - Chronic Disease
KW - Hypoxia/congenital
KW - Ion Transport/drug effects
KW - Nerve Tissue Proteins/drug effects
KW - Nifedipine/pharmacology
KW - Peptides/pharmacology
KW - Rats
KW - omega-Conotoxin GVIA
UR - http://www.scopus.com/inward/record.url?scp=0030299859&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030299859&partnerID=8YFLogxK
UR - https://corescholar.libraries.wright.edu/ncbp/852
U2 - 10.1007/978-1-4615-5891-0_15
DO - 10.1007/978-1-4615-5891-0_15
M3 - Conference contribution
C2 - 9030285
AN - SCOPUS:0030299859
SN - 978-0-306-45490-5
SN - 978-1-4613-7702-3
VL - 410
T3 - Advances in Experimental Medicine and Biology
SP - 105
EP - 108
BT - Frontiers in Arterial Chemoreception
A2 - Zapata, Patricio
A2 - Eyzaguirre, Carlos
A2 - Torrance, Robert W.
PB - Springer New York
T2 - 13th International Symposium on Arterial Chemoreceptors
Y2 - 25 March 1996 through 29 March 1996
ER -